Enzalutamide – July 2021

• Brand names:
  • Xtandi®
• Pharmaceutical Company:
  • Astellas Pharma Australia Pty Ltd
• Condition/Indication: Castration resistant carcinoma of the prostate
• Meeting Date: July 2021
• Public Summary Document (PSD) July 2021 PBAC Meeting - (PDF 784KB)
• Public Summary Document (PSD) July 2021 PBAC Meeting - (Word 52KB)

Related Public Summary Documents

• Abiraterone – July 2021